T4K3.news
MHRA safety alert for gummies
Parents told to stop giving Nutrition Ignition Kids Gummies after undeclared melatonin was found and to dispose of the product safely.

The government agency urges immediate cessation and disposal of the gummies after tests detected undeclared melatonin.
MHRA warns parents stop giving Nutrition Ignition Kids Gummies after undeclared melatonin found
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised parents to stop using Nutrition Ignition Kids Magnesium Glycinate Gummies and to dispose of any remaining stock. Tests identified melatonin in two tested batches, with levels ranging from 1.5 to 1.7 mg per gummy. The product packaging recommended a daily dose of 1 or 2 gummies for children, but melatonin was not listed on the label.
Authorities acted quickly to remove the product from online retailers and advise households to store the gummies securely in a tamper-proof container out of reach of children until they can be disposed of at a pharmacy. Melatonin is a prescription medicine for sleep disorders and is not intended for unsupervised use in children. The MHRA notes that if a child experiences side effects such as drowsiness, headaches, dizziness, or abdominal pain, a healthcare professional should be contacted and the Yellow Card reporting scheme used. No serious side effects have been reported in studies of melatonin for licensed indications in children, but safety remains a concern when it is used without medical supervision.
Key Takeaways
"It is recommended that advice be sought from a healthcare professional if a child has any side effects that are of concern."
MHRA spokesman quoted in the article explaining steps for parents
"We advise any parent or caregiver to stop use of this product and safely dispose of it."
Dr Alison Cave, MHRA Chief Safety Officer
This episode highlights gaps in labeling and regulation for dietary supplements sold online. When a medicine appears in a product marketed as a vitamin or nutrition aid, the line between supplement and medicine blurs, raising questions about who verifies safety and labeling for child-focused items sold across platforms. The incident may intensify scrutiny on online retailers and push for tighter controls on what can be marketed as a child supplement. It also underscores the need for clear communication to parents about dosing and potential interactions with other sleep aids or medications, especially for families juggling busy schedules and varied routines.
Highlights
- Safety first when it comes to children’s supplements
- If it’s not on the label it shouldn’t be in a gummy
- Regulators must keep pace with online sales
- Parents deserve products with clear accurate labels
Safety risk from undeclared melatonin in children's gummies
The product contained undeclared melatonin and was pulled from sale, raising concerns about labeling gaps and oversight of online sales for child-focused supplements.
Regulators will watch how retailers respond and whether labeling rules tighten in the coming months.
Enjoyed this? Let your friends know!
Related News

Gummy recall due to unlisted melatonin

UKHSA warns public about contaminated wet wipes

UKHSA issues wet wipe safety warning

UK Health Agency warns against using contaminated wet wipes

Health alert issued for non-sterile skin cleansing wipes

Urgent recall for contaminated wet wipes

Appletiser recall update

Emergency alert test set for September 7
